Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Effects of DAAs in HCV
NCT03296930Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Oct 2017
- Primary completion
- Sep 2018
- Modality
- Allosteric Modulators, Orthosteric Ligands
01
Overview
A Phase 4 trial of sofosbuvir, ombitasvir, paritaprevir, ritonavir in hepatitis C (HCV), sponsored by Assiut University. Status: unknown.
02
Drugs
sofosbuvirombitasvirparitaprevirritonavir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03296930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03296930.